SCHEMBL21972579

SCHEMBL21972579

N#CCC(=O)NNC(=S)Nc1ccc(Cl)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
GAA P10253 5/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NOX1 Q9Y5S8 1/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
KDM4E B2RXH2 3/20 0.54
MAPT P10636 2/20 0.54
PKM P14618 1/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MAPK1 P28482 1/20 0.51
PTGS2 P35354 1/20 0.49
CDC7 O00311 1/20 0.49
PLK4 O00444 1/20 0.49
AURKA O14965 1/20 0.49
PDPK1 O15530 1/20 0.49
DAPK3 O43293 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19277777 0.85 GAA (0.49) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL21972580 0.85 GAA (0.67) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL21973099 0.85 GAA (0.58) ALDH1A1GAANOX1MEN1KMT2A
SCHEMBL19277826 0.85 GAA (0.63) ALDH1A1GAANOX1MEN1KMT2A
SCHEMBL19260918 0.85 MAPT (0.54) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL29410073 0.85 MAPT (0.54) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL21972564 0.84 ALDH1A1 (0.62) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL21972740 0.83 NPC1 (0.59) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL21972737 0.83 GAA (0.56) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL21973098 0.83 SMN1; SMN2 (0.52) ALDH1A1GAAL3MBTL1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136291-B2 Antifungal compounds and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-10-05 US disclosed
US-20210147351-A9 ANTIFUNGAL COMPOUNDS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-05-20 US disclosed
US-20200140381-A1 ANTIFUNGAL COMPOUNDS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147351-A9 ANTIFUNGAL COMPOUNDS AND USES THEREOF ERG28, DPM1, CYP51A1 ALDH1A1 1944/4885GAA 9/4885L3MBTL1 1401/4885
US-20200140381-A1 ANTIFUNGAL COMPOUNDS AND USES THEREOF ERG28, DPM1, CYP51A1 ALDH1A1 1944/4885GAA 9/4885L3MBTL1 1401/4885
US-11136291-B2 Antifungal compounds and uses thereof ERG28, DPM1, CYP51A1 ALDH1A1 1944/4885GAA 9/4885L3MBTL1 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.